Compliance certificate under Reg. 74(5) of SEBI (DP) reg.2018 for the quarter ended 31.03.2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shukra Pharmaceuticals has submitted a compliance certificate under SEBI's Depository Regulations for the January–March 2025 quarter. This certificate, filed by the company's Registrar and Share Transfer Agent (RTA), confirms that all share certificates received for dematerialisation have been properly processed, cancelled, and destroyed during the quarter. It also confirms that the registers of members are being maintained accurately. This is a standard quarterly filing mandated by SEBI and does not involve any change in share capital, ownership, or business operations.
This is a routine regulatory compliance filing with no material impact on the company's financials, business, or shareholders. It simply confirms proper handling of dematerialisation requests and carries no positive or negative signal for the stock price.